Ignite Creation Date:
2024-05-06 @ 7:59 PM
Last Modification Date:
2024-10-26 @ 3:18 PM
Study NCT ID:
NCT06216002
Status:
RECRUITING
Last Update Posted:
2024-01-22
First Post:
2023-11-13
Brief Title:
Incidence of Residual Neuromuscular Blockade in Fraility in OncoGynae Surgery
Sponsor:
Mahidol University
Organization:
Mahidol University
Study Overview
Official Title:
Incidence of Residual Neuromuscular Blockade in Patients With Frailty Undergoing Gynecologic Cancer Surgery
Status:
RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
FIGO
Brief Summary:
Frailty among patients undergoing surgery is strongly associated with an elevated risk of adverse perioperative outcomes heightened incidence of postoperative complications increased mortality rates and prolonged hospital length of stay Our focus centers on investigating the frailty index in the context of complications experienced by patients undergoing oncologic gynecology surgery The principal objective of this research is to elucidate the extent to which residual neuromuscular blocking agents are linked to frailty
Detailed Description:
Among patients undergoing oncologic gynecological procedures such as those for vulvar cancer endometrial cancer and ovarian cancer the incidence of frailty has been observed to range from 14 to 45 Frailty directly influences the metabolism of anesthetic agents and intraoperative management Furthermore the prevalence of residual neuromuscular blocking agents following surgery can be as high as 26 to 53 No prior research has investigated the correlation between residual muscle relaxants and frailty in gynecologic oncology patients This study is designed to assess the prevalence of residual muscle relaxants in these patients with frailty Additionally data on the incidence of frailty and its impact on postoperative outcomes and prognosis in patients undergoing gynecologic oncology surgery will be collected and reported
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None